Neonatal Cardiac Fatty Acid Metabolism

Lam, Victoria Hol Mun

Permanent link:http://hdl.handle.net/10402/era.25301

Download Add to Cart

More Like This

Identifier:http://hdl.handle.net/10402/era.25301
Title or Caption:Neonatal Cardiac Fatty Acid Metabolism
Author or Creator:Lam, Victoria Hol Mun
Language:English
Subject keyword(s):Neonatal, newborn, cardiac, heart, congenital heart defect, fatty acid beta oxidation, metabolism, PPARalpha, cardiac hypertrophy
1 Introduction
2 Supra-physiological Insulin Levels Elevate Palmitate Oxidation to Improve Neonatal Rabbit Heart Ischemia-Reperfusion Recovery
3 Neonatal Rabbit Aorto-Caval Shunt Volume-Overload Cardiac Hypertrophy Model
4 Cardiac Hypertrophy in the Newborn Delays the Maturation of Fatty Acid β-Oxidation and Compromises Post-ischemic Functional Recovery
5 Activating Peroxisome Proliferator-Activated Receptor  Prevents Post-Ischemic Contractile Dysfunction in the Hypertrophied Neonatal Heart
6 General discussion
Date Accepted:Jan 29, 2012 6:52 PM
Type of Item:Thesis
Language:English
Format(s):Adobe PDF
File size(s):9526408 bytes
Abstract:The surgical repair of congenital heart defects (CHDs) often requires a bloodless/motionless field achieved by arresting the neonatal heart and exposing it to a period of ischemia. Metabolic manipulation, such as suppression of fatty acid (FA) oxidation, improves post-ischemic functional recovery in adult hearts. However, the metabolic profile of a neonatal heart differs dramatically from that of an adult. The neonatal heart is highly dependent on FA oxidation while glucose metabolic rates remain low until weaning. Since the neonatal myocardium is a FA-centered metabolism, then, unlike the adult heart, augmenting FA oxidation may improve its post-ischemic function recovery by increasing ATP available to the myocardium. In these studies, hearts were isolated from relevant neonatal rabbit models to study insulin’s effect, neonatal volume-overload hypertrophy, neonatal cardiac hypertrophy treated with a peroxisome proliferator activated-receptor-Α (PPARΑ) agonist. The hearts were perfused ex vivo to assess changes in cardiac metabolism and post-ischemic functional recovery associated with each treatment. The results demonstrate that high fat alters the neonatal heart’s response to insulin to increase FA oxidation and improve post-ischemic functional recovery. In contrast, neonatal cardiac hypertrophy downregulates FA metabolism and is associated with poor post-ischemic functional recovery. The administration of a PPARΑ agonist upregulated the FA metabolic pathway; therefore, FA metabolism increased and rescued the metabolic phenotype associated with cardiac hypertrophy and normalized post-ischemic functional recovery. In conclusion, augmenting FA oxidation with clinical levels of insulin in the normal neonatal heart and or a PPARΑ agonist in hypertrophied neonatal hearts improves post-ischemic functional recovery and may be a viable therapy of ischemia-reperfusion protection.
Degree Level:Doctoral
Degree:Doctor of Philosophy
Department:Medical Sciences-Paediatrics
Graduation date:Spring 2012
Supervisor and their department :Dr. Gary D Lopaschuk, Pediatrics
Dr. Ivan M Rebeyka, Surgery
Examining committee members and their departments:Dr. Jason R Dyck, Pediatrics
Dr. Thomas D Scholz, Pediatrics
Dr. Zamaneh Kassiri, Physiology
Dr. Peter E Light, Pharmacology

License Information

University of Alberta Libraries

Download license

CommunityFaculty of Graduate Studies and Research
CollectionTheses and Dissertations Spring 2009 to present
DepartmentMedical Sciences-Paediatrics

QRCode for: http://hdl.handle.net/10402/era.25301 QR Code for this page URL: http://hdl.handle.net/10402/era.25301

Advanced Search

License Information

Delete your item from era

Resotre your item to era

Purge your item from era

Remove your item from era

Quick Links

Policies

Get Help

University of Alberta